Comparison of the effects of combined rate and rhythm control treatment with Nebivolol and electric cardioversion to rate-control treatment with Nebivolol alone on clinical and echocardiographic parameters in patients with Left ventricular dysfunction induced tachycardia

Trial Profile

Comparison of the effects of combined rate and rhythm control treatment with Nebivolol and electric cardioversion to rate-control treatment with Nebivolol alone on clinical and echocardiographic parameters in patients with Left ventricular dysfunction induced tachycardia

Completed
Phase of Trial: Phase III

Latest Information Update: 05 Feb 2010

At a glance

  • Drugs Nebivolol (Primary)
  • Indications Left ventricular dysfunction; Tachycardia
  • Focus Registrational; Therapeutic Use
  • Acronyms NEBICAR
  • Sponsors Berlin Chemie
  • Most Recent Events

    • 07 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top